Edition:
United Kingdom

People: DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

143.52USD
25 Jun 2019
Change (% chg)

-- (--)
Prev Close
$143.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
455,218
52-wk High
$157.50
52-wk Low
$90.62

Sayer, Kevin 

Mr. Kevin R. Sayer serves as Chairman of the Board, President, Chief Executive Officer of DexCom Inc. He has served on our Board since November 2007, as our President since June 2011 and as our Chairman of the Board since July 2018. From January 2013 until January 2015, Mr. Sayer also served as our Chief Operating Officer. In connection with Mr. Gregg assuming a new role as Executive Chairman of the Board of Directors, Mr. Sayer assumed the role of Chief Executive Officer effective on January 1, 2015. From April 2007 to December 2010, Mr. Sayer served as Chief Financial Officer of Biosensors International Group, Ltd. ("Biosensors"), a medical technology company developing, manufacturing and commercializing medical devices used in interventional cardiology and critical care procedures. Prior to joining Biosensors, from May 2005 to April 2007, Mr. Sayer served as an independent healthcare and medical technology industry consultant. From March 2004 to May 2005, Mr. Sayer was Executive Vice President and Chief Financial Officer of Specialty Laboratories, Inc., a company offering clinical reference laboratory services. From August 2002 to March 2004, Mr. Sayer worked as an independent healthcare and medical technology industry consultant. Mr. Sayer served as Chief Financial Officer of MiniMed, Inc. from May 1994 until it was acquired by Medtronic, Inc. in August 2001. Mr. Sayer served as Vice President and General Manager of Medtronic MiniMed after the acquisition until August 2002. Mr. Sayer is a Certified Public Accountant (inactive) and received his Master's Degree in Accounting and Information Systems concurrently with a B.A., both from Brigham Young University. As CEO, Mr. Sayer has direct responsibility for our strategy and operations..

Basic Compensation

Total Annual Compensation, USD 1,862,980
Restricted Stock Award, USD 7,668,730
Long-Term Incentive Plans, USD --
All Other, USD 22,422
Fiscal Year Total, USD 9,554,120

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 87,270 9,525,910.00
Name Fiscal Year Total

Kevin Sayer

9,554,120

Quentin Blackford

3,391,640

Jake Leach

--

Donald Abbey

2,919,160

Andrew Balo

3,174,640

Richard Doubleday

3,207,460
As Of  31 Dec 2018